Your browser doesn't support javascript.
loading
Undetectable peripheral blood MRD should be the goal of venetoclax in CLL, but attainment plateaus after 24 months.
Lew, Thomas E; Anderson, Mary Ann; Lin, Victor S; Handunnetti, Sasanka M; Came, Neil A; Blombery, Piers; Westerman, David A; Wall, Meaghan; Tam, Constantine S; Roberts, Andrew W; Seymour, John F.
Afiliação
  • Lew TE; Department of Clinical Haematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Australia.
  • Anderson MA; Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
  • Lin VS; Department of Clinical Haematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Australia.
  • Handunnetti SM; Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
  • Came NA; Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
  • Blombery P; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia.
  • Westerman DA; Department of Clinical Haematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Australia.
  • Wall M; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Tam CS; Department of Clinical Haematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Australia.
  • Roberts AW; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia.
  • Seymour JF; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia.
Blood Adv ; 4(1): 165-173, 2020 01 14.
Article em En | MEDLINE | ID: mdl-31935286
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article